2018C&EN Global EnterpriseRequires access

Searching for cheaper malaria medicines

Mark Peplow

Open publisher page 7 citations

Abstract

In 2016, malaria killed an estimated 445,000 people, 90% of them in Africa. That’s one death every 71 seconds, caused by a disease that is both preventable and treatable. Although that death toll has fallen by 25% since 2010, the World Health Organization recently warned that progress has stalled and called for a redoubled assault on this scourge. Some of the most crucial weapons in this battle are artemisinin-based combination therapies (ACTs), judged to be the most effective antimalarial medicines. They contain derivatives of artemisinin, a molecule found in the plant sweet wormwood (Artemisia annua) that is grown mostly in China and Vietnam. But over the past 15 years, the world’s supply of artemisinin has been wildly erratic. As more farmers planted A. annua to meet rising demand, artemisinin supplies rose and pushed prices down. So farmers switched to more lucrative crops. Artemisinin supplies then plummeted and prices soared again.

About this research paper

What this paper is about

In 2016, malaria killed an estimated 445,000 people, 90% of them in Africa. That’s one death every 71 seconds, caused by a disease that is both preventable and treatable. Although that death toll has fallen by 25% since 2010, the World Health Organization recently warned that progress has stalled and called for a redoubled assault on this scourge. Some of the most crucial weapons in this battle are artemisinin-based combination therapies (ACTs), judged to be the most effective antimalarial medicines. They contain derivatives of artemisinin, a molecule found in the plant sweet wormwood (Artemisia annua) that is grown mostly in China and Vietnam. But over the past 15 years, the world’s supply of artemisinin has been wildly erratic. As more farmers planted A. annua to meet rising demand, artemisinin supplies rose and pushed prices down. So farmers switched to more lucrative crops. Artemisinin supplies then plummeted and prices soared again.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In 2016, malaria killed an estimated 445,000 people, 90% of them in Africa. That’s one death every 71 seconds, caused by a disease that is both preventable and treatable. Although that death toll has fallen by 25% since 2010, the World Health Organization recently warned that progress has stalled and called for a redoubled assault on this scourge. Some of the most crucial weapons in this battle are artemisinin-based combination therapies (ACTs), judged to be the most effective antimalarial medicines. They contain derivatives of artemisinin, a molecule found in the plant sweet wormwood (Artemisia annua) that is grown mostly in China and Vietnam. But over the past 15 years, the world’s supply of artemisinin has been wildly erratic. As more farmers planted A. annua to meet rising demand, artemisinin supplies rose and pushed prices down. So farmers switched to more lucrative crops. Artemisinin supplies then plummeted and prices soared again.

Key concepts: Malaria, Medicine, Intensive care medicine, Computer science, Business, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Searching for cheaper malaria medicines — Research Paper | ScholarLens